Core Insights - The company reported a significant increase in both revenue and net profit for the third quarter of 2025, with revenue reaching 1.383 billion yuan and net profit at 170 million yuan, marking a year-on-year profit growth of 861.91% [1] - For the first three quarters of 2025, total revenue was 4.915 billion yuan, with a net profit of 907 million yuan, indicating a recovery in profitability and operational capability [1][5] Product Innovation - The company has focused on product innovation as a key strategy, launching a total of 71 new products in the first three quarters of 2025 [3] - The product strategy includes a dual approach of upgrading basic nutrients and breaking into specialized functional categories, which strengthens the consumer market while expanding into professional fields [3] - Notable product launches include a high-content vitamin K2 adult calcium series, which drove a 48% growth in the liquid calcium category, and a multi-layer tablet that continues to boost category growth [3] Channel Strategy - The company has implemented a differentiated inventory strategy to optimize the value chain across online and offline channels, with positive adjustments becoming evident [4] - In offline channels, the company has improved market share in the protein powder category by 3.3 percentage points, driven by the calcium vitamin E protein powder [4] - Online, the company has focused on professional, segmented, and high-end upgrades, with new products performing well on e-commerce platforms, including a new high-content vitamin K2 liquid calcium series targeting specific demographics [4] Research and Development - The company has made significant advancements in research and development, holding 487 patents and numerous certifications for health food products, positioning itself at the forefront of the industry [5] - The company has also enhanced its brand image by becoming a partner in significant scientific exploration projects, further establishing its professional reputation [5] Overall Performance - Following a challenging year in 2024, the company has shown resilience through systematic adjustments across various dimensions, achieving notable reform results in a short time [5] - The ongoing release of new products and improvements in operational efficiency are expected to stabilize and support long-term growth [5]

Market Overview - The Shanghai Composite Index rose by 0.70% on October 29, with 24 out of 28 sectors experiencing gains, led by the power equipment and non-ferrous metals sectors, which increased by 4.79% and 4.28% respectively [1] - The banking and food & beverage sectors were the biggest losers, declining by 1.98% and 0.56% respectively [1] Capital Flow Analysis - The net inflow of capital in the two markets was 5.406 billion yuan, with 12 sectors seeing net inflows [1] - The power equipment sector had the highest net inflow of 16.132 billion yuan, while the non-ferrous metals sector followed with a net inflow of 5.997 billion yuan [1] - Conversely, 19 sectors experienced net outflows, with the electronics sector leading at a net outflow of 6.540 billion yuan, followed by the communications sector with 4.736 billion yuan [1] Food & Beverage Sector Performance - The food & beverage sector declined by 0.56% with a net outflow of 1.952 billion yuan [2] - Out of 124 stocks in this sector, 37 rose while 82 fell [2] - The top three stocks with net inflows were汤臣倍健 (Tao Chen Bei Jian) with 21.505 million yuan, 贝因美 (Bei Yin Mei) with 18.4737 million yuan, and 三元股份 (San Yuan) with 12.2605 million yuan [2] Food & Beverage Sector Outflow Details - The top three stocks with the highest net outflows were 贵州茅台 (Kweichow Moutai) with -679.3826 million yuan, 五粮液 (Wuliangye) with -555.1196 million yuan, and 泸州老窖 (Luzhou Laojiao) with -87.9085 million yuan [4] - Other notable outflows included 伊利股份 (Yili) with -39.2080 million yuan and 洋河股份 (Yanghe) with -20.6408 million yuan [4]

Group 1 - On October 29, 2023, Tongchen Beijian executed a block trade of 185,900 shares, with a transaction value of 2.2512 million yuan, accounting for 0.79% of the total trading volume for the day [1][2] - The transaction price was 12.11 yuan per share, representing a discount of 2.57% compared to the market closing price of 12.43 yuan [1][2]

Market Overview - The food processing sector increased by 0.66% on October 29, with Xianle Health leading the gains [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Top Gainers in Food Processing Sector - Xianle Health (300791) closed at 24.00, up 5.12% with a trading volume of 66,000 shares and a turnover of 158 million yuan [1] - Anjijia Food (603345) closed at 73.00, up 4.54% with a trading volume of 171,400 shares and a turnover of 1.243 billion yuan [1] - Kangbiter (920429) closed at 17.78, up 4.34% with a trading volume of 42,200 shares and a turnover of 71.648 million yuan [1] Top Losers in Food Processing Sector - ST Chuntian (600381) closed at 4.62, down 3.95% with a trading volume of 160,900 shares and a turnover of 74.493 million yuan [2] - Guanghong Holdings (000529) closed at 5.93, down 3.42% with a trading volume of 152,200 shares and a turnover of 90.343 million yuan [2] - Huifa Food (603536) closed at 10.86, down 2.78% with a trading volume of 104,600 shares and a turnover of 114 million yuan [2] Capital Flow Analysis - The food processing sector experienced a net outflow of 51.2618 million yuan from institutional investors, while retail investors saw a net inflow of 66.9266 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are increasing their positions [2] Individual Stock Capital Flow - Tongchen Beijian (300146) had a net inflow of 25.4486 million yuan from institutional investors, but a net outflow of 26.3022 million yuan from retail investors [3] - Shuanghui Development (000895) saw a net inflow of 6.5057 million yuan from institutional investors, while retail investors contributed a net inflow of 11.0663 million yuan [3] - Jinziham (002515) had a net inflow of 4.5988 million yuan from institutional investors, with retail investors also contributing a net inflow of 14.3141 million yuan [3]

Core Insights - The company reported a revenue of 4.915 billion yuan for the first three quarters of 2025, a year-on-year decrease of 14.27% [1] - Net profit attributable to shareholders reached 907 million yuan, an increase of 4.45% year-on-year [1] - The net profit excluding non-recurring gains and losses was 827 million yuan, up 2.44% year-on-year [1] - Basic earnings per share stood at 0.53 yuan [1] Quarterly Performance - In the third quarter of 2025, the company achieved a revenue of 1.383 billion yuan, reflecting a year-on-year increase of 23.45% [1] - Net profit attributable to shareholders for the third quarter was 171 million yuan, a significant increase of 861.91% year-on-year [1] - The net profit excluding non-recurring gains and losses for the third quarter was 133 million yuan, up 652.64% year-on-year [1] - Basic earnings per share for the third quarter was 0.10 yuan [1]

关于公司副总经理辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 证券代码：300146 证券简称：汤臣倍健 公告编号：2025-047 汤臣倍健股份有限公司 特此公告。 汤臣倍健股份有限公司 董 事 会 二〇二五年十月二十九日 1 汤臣倍健股份有限公司（以下简称"公司"）董事会于近日收到公司副总经 理蔡良平先生的书面辞职报告。蔡良平先生因工作调整原因，申请辞去公司副总 经理职务，辞职后蔡良平先生将继续在公司担任其他职务。蔡良平先生将按照相 关规定做好工作交接事宜，其辞职不会对公司的正常运作及经营管理产生影响。 蔡良平先生的辞职报告自送达公司董事会之日起生效，其副总经理职务原定任期 至公司第六届董事会任期届满之日止。 截至本公告披露日，蔡良平先生持有公司股份 536,000 股，占公司总股本的 0.0317%。蔡良平先生不存在应履行而未履行的承诺事项。蔡良平先生离任后， 其所持股份将严格遵守《中华人民共和国证券法》《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》《公司章程》等相关规定进行 管理。 蔡良平先生在任职期间恪尽职 ...

Financial Performance - The company's revenue for Q3 2025 reached ¥1,383,054,642.19, representing a 23.45% increase compared to the same period last year[4] - Net profit attributable to shareholders was ¥170,793,477.84, a significant increase of 861.91% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥133,489,600.03, up 652.64% from the previous year[4] - For the period of January to September 2025, the company achieved operating revenue of RMB 4.915 billion, a decrease of 14.27% compared to the same period last year[21] - The net profit attributable to shareholders for the same period was RMB 907 million, an increase of 4.45% year-on-year[21] - The main brand "汤臣倍健" generated revenue of RMB 2.676 billion, down 16.22% year-on-year, while "健力多" revenue was RMB 574 million, down 17.76%[21] - The overseas brand LSG reported revenue of RMB 720 million, an increase of 13.64% year-on-year, with an Australian dollar revenue of AUD 157 million, up 17.36%[21] - The company reported total operating revenue of CNY 4,915,367,069.98 for the first nine months of 2025, a decrease of 14.3% compared to CNY 5,733,545,680.89 in the same period last year[29] - The net profit attributable to the parent company was CNY 907,306,713.44, representing an increase of 4.5% from CNY 868,614,585.23 in the previous year[30] Cash Flow and Investments - The company's cash flow from operating activities for the year-to-date was ¥921,241,875.10, an increase of 170.13%[4] - Cash flow from operating activities for the period was RMB 921 million, a significant increase of 170.13% compared to RMB 341 million in the previous period[16] - The net cash flow from investing activities improved to -RMB 5.79 million, a reduction of 86.23% from -RMB 42 million in the previous period[16] - Total cash inflow from financing activities was RMB 1.095 billion, an increase of 100.88% compared to RMB 545 million in the previous period[16] - Operating cash inflow totaled ¥4,854,131,782.80, a decrease of 8.2% from ¥5,286,441,798.25 in the previous period[32] - Net cash flow from operating activities increased significantly to ¥921,241,875.10, compared to ¥341,030,743.31 in the prior period, marking a growth of 170.5%[34] - Cash inflow from financing activities was ¥1,094,994,555.47, up from ¥545,098,899.99, indicating a growth of 100.8%[34] - The company repaid debts totaling ¥1,564,776,824.55 during the financing activities, with cash outflow for dividends and interest payments at ¥605,820,466.36[34] - The net increase in cash and cash equivalents was -¥271,814,282.04, compared to -¥942,848,920.13 in the previous period, showing an improvement[34] - The ending balance of cash and cash equivalents stood at ¥2,320,090,290.78, slightly down from ¥2,380,868,570.36[34] Assets and Liabilities - The total assets at the end of the reporting period were ¥14,002,293,222.35, a decrease of 1.94% from the end of the previous year[4] - The company's cash and cash equivalents decreased to CNY 2,320,090,290.78 from CNY 2,596,956,308.44 at the beginning of the period, a decline of 10.6%[26] - The total assets of the company as of September 30, 2025, were CNY 14,002,293,222.35, down from CNY 14,279,753,758.79 at the beginning of the year, a decrease of 1.9%[26] - The company’s total liabilities decreased to CNY 2,604,185,580.52 from CNY 3,182,576,755.69, a reduction of 18.1%[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 71,105, with the largest shareholder holding 42.01% of the shares[17] - The company repurchased a total of 9,168,400 shares, accounting for 0.539% of the total share capital, with a total payment of RMB 105.2 million[22] Research and Development - Research and development expenses decreased by 52.44% to ¥55,327,026.73, mainly due to refunds received from outsourced R&D[13] - The company’s R&D expenses for the first nine months were CNY 55,327,026.73, down 52.4% from CNY 116,330,568.98 in the previous year[30] Governance and Other Information - The company has restructured its governance by eliminating the supervisory board and transferring its responsibilities to the audit committee[23] - The company reported a basic earnings per share of CNY 0.53, compared to CNY 0.51 in the same period last year[30] - The company reported a significant increase in non-operating income, with government subsidies contributing to a 41.87% rise in other income to ¥39,581,509.49[13] - The company's financial report for Q3 2025 is unaudited[36]

证券代码：300146 证券简称：汤臣倍健 公告编号：2025-045 汤臣倍健股份有限公司 第六届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、董事会会议召开情况 汤臣倍健股份有限公司（以下简称"公司"）第六届董事会第十八次会议于 2025年10月29日9:45在内蒙古自治区阿拉善盟阿拉善左旗巴彦浩特东关街1号会 议室以现场结合通讯表决方式召开。会议通知已于2025年10月24日以电子邮件方 式送达全体董事。本次会议应参加董事7人，实际参加董事7人，除董事林志成先 生、独立董事刘恒先生现场参会外，其他董事均以通讯方式参加。本次会议由公 司董事长梁允超先生召集和主持，董事会秘书唐金银女士列席会议。本次会议的 召集、召开符合《中华人民共和国公司法》（以下简称"《公司法》"）、《深 圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》以及 《公司章程》《董事会议事规则》的有关规定，会议合法有效。 二、 董事会会议审议情况 经与会董事认真审议，本次会议以表决票表决的方式形成以下决议： 1.审议通过了《2025年第三季度 ...

Core Insights - The company reported a third-quarter revenue of 1.383 billion yuan, representing a year-on-year increase of 23.45% [1] - The net profit for the third quarter was 171 million yuan, showing a significant year-on-year growth of 861.91% [1] - For the first three quarters, the company achieved a revenue of 4.915 billion yuan, which is a year-on-year decline of 14.27% [1] - The net profit for the first three quarters was 907 million yuan, reflecting a year-on-year increase of 4.45% [1]

外部信息使用人管理制度 第一条 为进一步提高汤臣倍健股份有限公司（以下简称"公司"）的规范 运作水平，强化公司定期报告、临时报告及重大事项在筹划、编制、审议和披露 等期间的外部信息报送和使用管理，现根据《中华人民共和国证券法》《上市公 司信息披露管理办法》《上市公司治理准则》《深圳证券交易所创业板股票上市 规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作》等法律、法规、规范性文件及《汤臣倍健股份有限公司章程》（以下简称 "《公司章程》"）、《汤臣倍健股份有限公司信息披露管理制度》（以下简称 "《信息披露管理制度》"）的有关规定，并结合公司实际情况，特制定本制度。 第二条 本制度所指信息是指依据《信息披露管理制度》之规定，可能对公 司股票及其衍生品种交易价格或者投资决策产生较大影响的信息或事项（以下简 称"重大信息或者重大事项"），包括但不限于定期报告、临时报告、财务数据、 统计数据及需报批的重大事项。 汤臣倍健股份有限公司 （二）外部单位或个人因保密不当致使公司未公开的重大信息被泄露的，应 当立即通知公司，公司应当在第一时间向深圳证券交易所报告并公告披露。 本制度所指外部信息使 ...